Article Details

FDA Approves New Long-Term Treatment for Myasthenia Gravis - WebMD

Retrieved on: 2025-05-02 20:37:59

Tags for this article:

Click the tags to see associated articles and topics

FDA Approves New Long-Term Treatment for Myasthenia Gravis - WebMD. View article details on hiswai:

Excerpt

Imaavy is a lab-made monoclonal antibody that works by selectively blocking a protein called FcRn. This helps reduce the levels of harmful antibodies ...

Article found on: www.webmd.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo